The Association Between β-Blocker Use and Cardiorespiratory Fitness: The Maastricht Study.
Johannes T H NielenFrank de VriesJeroen H P M van der VeldeHans H C M SavelbergNicolaas C SchaperPieter C DagnelieRonald M A HenryMiranda SchramCoen D A StehouwerAnnelies BoonenAnnemarie KosterBart J F van den BemtPublished in: Journal of cardiovascular pharmacology and therapeutics (2018)
β-Blockers use was associated with CRF based on the 6MWT but not the cycling test. There was no difference between current selective and nonselective BB users, possibly due to the small number of nonselective BB users, differential underlying diseases, other pharmacological properties, and limitations related to the proxies of the outcome.